S
Susan H. Fox
Researcher at University of Toronto
Publications - 220
Citations - 17609
Susan H. Fox is an academic researcher from University of Toronto. The author has contributed to research in topics: Dyskinesia & Parkinson's disease. The author has an hindex of 56, co-authored 208 publications receiving 14500 citations. Previous affiliations of Susan H. Fox include University of Manchester & University Health Network.
Papers
More filters
Journal ArticleDOI
Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): scale presentation and clinimetric testing results.
Christopher G. Goetz,Barbara C. Tilley,Stephanie R. Shaftman,Glenn T. Stebbins,Stanley Fahn,Pablo Martinez-Martin,Werner Poewe,Cristina Sampaio,Matthew B. Stern,Richard Dodel,Bruno Dubois,Robert G. Holloway,Joseph Jankovic,Jaime Kulisevsky,Anthony E. Lang,Andrew J. Lees,Sue Leurgans,Peter A. LeWitt,David L. Nyenhuis,C. Warren Olanow,Olivier Rascol,Anette Schrag,Jeanne A. Teresi,Jacobus J. van Hilten,Nancy R. LaPelle,Pinky Agarwal,Saima Athar,Yvette Bordelan,Helen Bronte-Stewart,Richard Camicioli,Kelvin L. Chou,Wendy Cole,Arif Dalvi,Holly Delgado,Alan Diamond,Jeremy P.R. Dick,John E. Duda,Rodger J. Elble,Carol Evans,V. G. H. Evidente,Hubert H. Fernandez,Susan H. Fox,Joseph H. Friedman,Robin D. Fross,David A. Gallagher,Deborah A. Hall,Neal Hermanowicz,Vanessa K. Hinson,Stacy Horn,Howard I. Hurtig,Un Jung Kang,Galit Kleiner-Fisman,Olga Klepitskaya,Katie Kompoliti,Eugene C. Lai,Maureen L. Leehey,Iracema Leroi,Kelly E. Lyons,Terry McClain,Steven W. Metzer,Janis M. Miyasaki,John C. Morgan,Martha Nance,Joanne Nemeth,Rajesh Pahwa,Sotirios A. Parashos,Jay S. Schneider,Kapil D. Sethi,Lisa M. Shulman,Andrew Siderowf,Monty Silverdale,Tanya Simuni,Mark Stacy,Robert Malcolm Stewart,Kelly L. Sullivan,David M. Swope,Pettaruse M. Wadia,Richard Walker,Ruth H. Walker,William J. Weiner,Jill Wiener,Jayne R. Wilkinson,Joanna M. Wojcieszek,Summer C. Wolfrath,Frederick Wooten,Allen Wu,Theresa A. Zesiewicz,Richard M. Zweig +87 more
TL;DR: The combined clinimetric results of this study support the validity of the MDS‐UPDRS for rating PD.
Journal ArticleDOI
The Movement Disorder Society Evidence-Based Medicine Review Update: Treatments for the non-motor symptoms of Parkinson's disease
Klaus Seppi,Daniel Weintraub,Miguel Coelho,Santiago Perez-Lloret,Susan H. Fox,Regina Katzenschlager,Eva-Maria Hametner,Werner Poewe,Olivier Rascol,Christopher G. Goetz,Cristina Sampaio +10 more
TL;DR: The objective of this work was to update previous EBM reviews on treatments for PD with a focus on non‐motor symptoms and found that most of the other interventions there is insufficient evidence to make adequate conclusions on their efficacy.
Journal ArticleDOI
International Parkinson and movement disorder society evidence‐based medicine review: Update on treatments for the motor symptoms of Parkinson's disease
Susan H. Fox,Regina Katzenschlager,Shen-Yang Lim,Brandon R. Barton,Rob M.A. de Bie,Klaus Seppi,Miguel Coelho,Cristina Sampaio +7 more
TL;DR: The objective of this review was to update evidence‐based medicine recommendations for treating motor symptoms of Parkinson's disease with new recommendations for treatment of central nervous system symptoms.
Journal ArticleDOI
Update on treatments for nonmotor symptoms of Parkinson's disease—an evidence-based medicine review
Klaus Seppi,K. Ray Chaudhuri,Miguel Coelho,Susan H. Fox,Regina Katzenschlager,Santiago Perez Lloret,Daniel Weintraub,Daniel Weintraub,Cristina Sampaio,Cristina Sampaio +9 more
TL;DR: To update evidence‐based medicine recommendations for treating nonmotor symptoms in Parkinson's disease, the World Health Organization (WHO) selected Austria as a preferred destination for research and clinical trials.
Journal ArticleDOI
Prevalence of repetitive and reward-seeking behaviors in Parkinson disease
Valerie Voon,K. Hassan,Mateusz Zurowski,M. de Souza,Teri Thomsen,Susan H. Fox,Anthony E. Lang,Janis M. Miyasaki +7 more
TL;DR: This study surveyed 297 patients with Parkinson disease with systematic screens and rigorous definitional criteria and found pathologic hypersexuality lifetime prevalence was 2.4%, which increases to 13.7% in patients on dopamine agonists.